EW
32
3
RRC
60
-3
CHD
48
-3
TRV
56
-2
PCG
99
2
DGX
48
-3
SE
60
-5
RCL
88
-2
TEL
74
3
WDC
38
-3
NWS
79
-4
STI
31
19
CF
53
2
SWKS
33
-10
ADI
45
-5
LEN
52
2
SCHW
65
-2
INTC
49
16
EQT
57
-3
AIZ
78
2
EW
32
3
RRC
60
-3
CHD
48
-3
TRV
56
-2
PCG
99
2
DGX
48
-3
SE
60
-5
RCL
88
-2
TEL
74
3
WDC
38
-3
NWS
79
-4
STI
31
19
CF
53
2
SWKS
33
-10
ADI
45
-5
LEN
52
2
SCHW
65
-2
INTC
49
16
EQT
57
-3
AIZ
78
2
Financhill
Back

Repligen Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
62

RGEN
Repligen

Last Price:
142.17
Seasonality Move:
7.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Repligen Price Quote

$142.17
-8.26 (-5.49%)
(Updated: November 14, 2024 at 5:15 PM ET)

Repligen Key Stats

Buy
62
Repligen (RGEN) is a Buy
Day range:
$143.95 - $154.32
52-week range:
$113.50 - $211.13
Dividend yield:
0%
P/E ratio:
200.80
P/S ratio:
13.92
P/B ratio:
4.19%
Volume:
1.1M
Avg. volume:
573.2K
1-year change:
3.25%
Market cap:
$8.3B
Revenue:
$638.8M
EPS:
$-0.04

How Much Does Repligen Make?

  • How Much Are Repligen's Sales Annually?
    RGEN Revenues are $638.8M
  • How Much Profit Does Repligen's Make A Year?
    RGEN net income is $41.6M

Is Repligen Growing As A Company?

  • What Is Repligen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.03%
  • What Is Repligen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.83%

Repligen Stock Price Performance

  • Did Repligen Stock Go Up Last Month?
    Repligen share price went up by 8.36% last month
  • Did RGEN's Share Price Rise Over The Last Year?
    RGEN share price rose by 3.25% over the past 1 year

What Is Repligen 52-Week High & Low?

  • What Is Repligen’s 52-Week High Share Price?
    Repligen has traded as high as $211.13 over the past 52 weeks
  • What Is Repligen’s 52-Week Low Share Price?
    Repligen has traded as low as $113.50 over the past 52 weeks

Repligen Price To Free Cash Flow

  • Is Repligen Stock Overvalued?
    Repligen is trading at a price to free cash flow ratio of 70.31
  • Is Repligen Stock Undervalued?
    Repligen EV to Free Cash Flow ratio is 67.92
  • What Is Repligen’s Price Earnings Growth Ratio?
    RGEN PEG ratio is 0.00
  • Is Repligen Trading At A Premium To Earnings?
    Repligen EV to EBIT ratio is 377.54

Is It Risky To Buy Repligen?

  • How Much Debt Does Repligen Have?
    Total long term debt quarterly is $587.2M
  • How Much Cash Does Repligen Have?
    Cash and short term investments quarterly total is $809.1M
  • What Is Repligen’s Book Value Per Share?
    Book value per share is 35.53

Is Repligen Cash Flow Positive?

  • What Is RGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $155.2M
  • What Is Repligen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $252.6M
  • What Is Repligen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$194.4M

Repligen Return On Invested Capital

  • Is Management Doing A Good Job?
    RGEN return on invested capital is -0.08%
  • What Is Repligen Return On Assets?
    ROA measures how assets are converting to revenues and is -0.07%
  • What Is RGEN Return On Equity?
    ROE is a measure of profitability and is -0.1%

Repligen Earnings Date & Stock Price

  • What Is Repligen's Stock Price Today?
    A single share of RGEN can be purchased today for 150.43
  • What Is Repligen’s Stock Symbol?
    Repligen trades on the nasdaq under the ticker symbol: RGEN
  • When Is Repligen’s Next Earnings Date?
    The next quarterly earnings date for Repligen is scheduled on February 21, 2025
  • When Is RGEN's next ex-dividend date?
    Repligen's next ex-dividend date is November 14, 2024
  • How To Buy Repligen Stock?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Repligen Competitors

  • Who Are Repligen's Competitors?
    Below is a list of companies who compete with Repligen or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • QuidelOrtho Corp (QDEL)
    • Catheter Precision Inc (VTAK)
    • West Pharmaceutical Services Inc (WST)
    • Xtant Medical Holdings Inc (XTNT)

Repligen Dividend Yield

  • What Is RGEN Dividend Yield?
    Repligen’s dividend yield currently is 0%
  • What Is Repligen’s Payout Ratio?
    Repligen’s payout ratio is 0%
  • When Did Repligen Last Pay A Dividend?
    The latest dividend pay date is November 14, 2024
  • What Is Repligen’s Dividend Per Share?
    Repligen pays a dividend of $0.00 per share

Repligen Analyst Estimates

YoY Growth Past Surprise
EPS: -82.86% 29.38%
Revenue: -3.2% 1.03%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 191.83
Upside from Last Price: 27.52%

Major Shareholders

  • How many RGEN shares are owned by institutional investors?
    92M RGEN shares are owned by institutional investors
  • How many RGEN shares are owned by insiders?
    2.5M RGEN shares are owned by insiders